nivolumab,ipilimumab
ono Pharmaceuticals,bms
['bcsm', 'bellini']
conclusions putting the bellini data into perspective #bcsm #esmo22 
Med Onc, Clinical Trials Development Leader @JulesBordet #BreastCancer #PrecisionMedicine. Views are mine https://t.co/PeEXATwb02